


Healthcare Industry NewsFeed
HSMN NewsFeed - 7 Dec 2017
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 7 Dec 2017
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
HSMN NewsFeed - 7 Dec 2017
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
HSMN NewsFeed - 7 Dec 2017
Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
Dr. Aradhana Ghosh Joins Precision Medicine Leader Syapse As Vice President of Oncology
HSMN NewsFeed - 7 Dec 2017
Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
HSMN NewsFeed - 7 Dec 2017
Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences
Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences
HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
HSMN NewsFeed - 5 Dec 2017
Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
Lia Diagnostics Announces FDA Clearance Of The First And Only Flushable, Biodegradable Pregnancy Test
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 5 Dec 2017
AccuTec Blades(R) Announces Exclusive Australia-New Zealand DermaBlade(R) Agreement
AccuTec Blades(R) Announces Exclusive Australia-New Zealand DermaBlade(R) Agreement
HSMN NewsFeed - 5 Dec 2017
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
HSMN NewsFeed - 4 Dec 2017
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
HSMN NewsFeed - 4 Dec 2017
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 1 Dec 2017
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
FDA approves first biosimilar for the treatment of certain breast and stomach cancers
HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
HSMN NewsFeed - 30 Nov 2017
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
HSMN NewsFeed - 30 Nov 2017
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel
HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
HSMN NewsFeed - 30 Nov 2017
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors
HSMN NewsFeed - 29 Nov 2017
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
HSMN NewsFeed - 28 Nov 2017
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
Upsher-Smith Launches KLOR-CON(R) Powder (Potassium Chloride) For Oral Solution
